Malika Aid
Overview
Explore the profile of Malika Aid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dagotto G, Colarusso A, Patio R, Li D, Anioke T, Giffin V, et al.
J Immunother Cancer
. 2024 Dec;
12(12).
PMID: 39694702
Background: Neoantigens are promising immunogens for cancer vaccines and are often delivered as adjuvanted peptide vaccines. Adenoviral (Ad) vectors have been shown to induce strong CD8 T cell responses as...
2.
Nkolola J, Hope D, Guan R, Colarusso A, Aid M, Weiss D, et al.
J Virol
. 2024 Nov;
98(12):e0142924.
PMID: 39545728
Zika virus (ZIKV) is a mosquito-borne flavivirus that caused a global pandemic in 2016-2017 with continued ongoing transmission at low levels in several countries. In the absence of an approved...
3.
Blass E, Colarusso A, Aid M, Larocca R, Reeves R, Barouch D
bioRxiv
. 2024 Oct;
PMID: 39464013
As the first responder to immunological challenges, the innate immune system shapes and regulates the ensuing adaptive immune response. Many clinical studies evaluating the role of innate immunity in initiating...
4.
Julg B, Walker-Sperling V, Wagh K, Aid M, Stephenson K, Zash R, et al.
Nat Med
. 2024 Sep;
30(12):3534-3543.
PMID: 39266747
Human immunodeficiency virus type 1 (HIV-1)-specific broadly neutralizing monoclonal antibodies (bNAbs) have to date shown transient viral suppression when administered as monotherapy or as a cocktail of two antibodies. A...
5.
McMahan K, Wegmann F, Aid M, Sciacca M, Liu J, Hachmann N, et al.
Nature
. 2023 Dec;
626(7998):385-391.
PMID: 38096903
A limitation of current SARS-CoV-2 vaccines is that they provide minimal protection against infection with current Omicron subvariants, although they still provide protection against severe disease. Enhanced mucosal immunity may...
6.
Aid M, Stephenson K, Collier A, Nkolola J, Michael J, McKenzie S, et al.
Nat Commun
. 2023 Oct;
14(1):6703.
PMID: 37872311
Thrombosis with thrombocytopenia syndrome (TTS) is a rare but potentially severe adverse event following immunization with adenovirus vector-based COVID-19 vaccines such as Ad26.COV2.S (Janssen) and ChAdOx1 (AstraZeneca). However, no case...
7.
Aid M, Sciacca M, McMahan K, Hope D, Liu J, Jacob-Dolan C, et al.
Cell
. 2023 Sep;
186(21):4652-4661.e13.
PMID: 37734373
The mpox outbreak of 2022-2023 involved rapid global spread in men who have sex with men. We infected 18 rhesus macaques with mpox by the intravenous, intradermal, and intrarectal routes...
8.
Aid M, Colarusso A, Walker-Sperling V, Barouch D
Cell Rep Med
. 2023 Jul;
4(7):101122.
PMID: 37467721
The discovery of biomarkers that predict viral rebound after discontinuation of antiretroviral therapy (ART) would significantly contribute to the HIV cure field. We previously initiated ART in 20 rhesus macaques...
9.
Vidal S, Sellers D, Yu J, Wakabayashi S, Sixsmith J, Aid M, et al.
iScience
. 2023 Jun;
26(6):106963.
PMID: 37378347
Bacillus Calmette-Guérin (BCG) remains the only approved tuberculosis (TB) vaccine despite limited efficacy. Preclinical studies of next-generation TB vaccines typically use a murine aerosol model with a supraphysiologic challenge dose....
10.
He X, Aid M, Ventura J, Borducchi E, Lifton M, Liu J, et al.
J Virol
. 2022 Aug;
96(17):e0080822.
PMID: 36000842
The mechanisms underlying depletion of CD4 T cells during acute HIV-1 infection are not well understood. Here we show that caspase-1-induced pyroptosis, a highly inflammatory programmed cell death pathway, is...